Advancements in Pulsed Bioenergy Therapies for Inflammatory Disorders

Monday, April 8, 2024

4:30pm - 6:00pm

Location:Governor's D - 4th Floor

Effective bioenergy treatment requires validation by a quantitative endpoint. Elastography and 3D Doppler histogram of vessel density (tumor or inflammatory) are clinically useful.
One of the biggest challenges in validating the effects of therapies is that the exact biological mechanisms by which they exert their healing effects are not always specifically known, or they may not know how to objectively measure them. How our genes and epigenetic changes get translated into health relies on genetic expression, and this can be measured directly or indirectly through laboratory technologies.

Moderator(s)

ROBERT BARD, MD DABR FAIUM FASLMS

director
Angiofoundation

Session Speaker(s)

ROBERT BARD, MD DABR FAIUM FASLMS

director
Angiofoundation

Industry Speaker(s)

Roberta Kline, MD (she/her/hers)

Founder
Roberta Kline Functional Genomics Consulting
Pat Ziemer

Learning Objectives:

Utilize bioenergy therapies for improved patient outcomes in clinical settings
Identify and select the most suitable bioenergy treatment modality for specific clinical disorders.
Gain proficiency in assessing when to incorporate additional imaging techniques.
Learn to broaden diagnostic and clinical testing methods for assessing the efficacy of bioenergetic modalities in treatment plans.
Deepen knowledge about the fundamental role of genetic expression in the development and treatment of inflammatory diseases.
Acquire a thorough understanding of the factors influencing gene expression related to bioenergy therapies.

Presentations:

4:30pm - 5:00pm

Microvascular Imaging
ROBERT BARD, MD DABR FAIUM FASLMS – Angiofoundation
5:00pm - 5:30pm

Overview/Pulsed Bioenergy Therapy
Pat Ziemer
5:30pm - 6:00pm

Benefits of Genetic Expression in Assessing Efficacy of Bioenergetic Interventions
Roberta Kline, MD (she/her/hers) – Roberta Kline Functional Genomics Consulting